Literature DB >> 27016920

Hyperbaric oxygen therapy as an alternative to surgery for non-healing pharyngocutaneous fistula.

Rani Abu Eta1,2, Ephraim Eviatar1,2, Haim Gavriel3,4.   

Abstract

The aim of the study is to examine the utilization of hyperbaric oxygen treatment (HBOT) as an alternative to surgical treatment for non-healing postoperative phayngocutaneous fistula (POPCF). A retrospective study was conducted between 2012 and 2014 of referred patients who had failed conservative treatment for POPCF at other medical centers. Reevaluation at our department was followed by therapeutic management including daily HBOT. Eight male patients with a mean age of 62.3 years were included. The average period of conservative treatment was 1 month before admittance to our department. All patients were managed with HBOT and local debridement. Closure of the POPCF was proved by a barium swallow test in seven patients (87.5 %). HBOT is recommended for patients who have failed conservative treatment for POPCF post-laryngectomy, due to a high rate of successful (87.5 %) closure and should be considered as an alternative to surgical treatment.

Entities:  

Keywords:  Deglutition; Deglutition disorders; Hyperbaric oxygen therapy; Pharyngocutaneous fistula; Surgery; Treatment

Mesh:

Year:  2016        PMID: 27016920     DOI: 10.1007/s00405-016-4002-9

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  29 in total

1.  Postlaryngectomy pharyngocutaneous fistula: incidence, predisposing factors, and therapy.

Authors:  L O Redaelli de Zinis; L Ferrari; D Tomenzoli; G Premoli; G Parrinello; P Nicolai
Journal:  Head Neck       Date:  1999-03       Impact factor: 3.147

2.  Assessment and incidence of salivary leak following laryngectomy.

Authors:  Hilliary N White; Blake Golden; Larissa Sweeny; William R Carroll; Jeffery S Magnuson; Eben L Rosenthal
Journal:  Laryngoscope       Date:  2012-05-30       Impact factor: 3.325

3.  Postoperative complications of salvage total laryngectomy.

Authors:  Ian Ganly; Snehal Patel; Jeanette Matsuo; Bhuvanesh Singh; Dennis Kraus; Jay Boyle; Richard Wong; Nancy Lee; David G Pfister; Ashok Shaha; Jatin Shah
Journal:  Cancer       Date:  2005-05-15       Impact factor: 6.860

4.  [Results of operations of salvage laryngectomy].

Authors:  J Brugère; J Rodriguez; D Point; P Thanh
Journal:  Ann Otolaryngol Chir Cervicofac       Date:  1987

5.  The management of post-operative pharyngo-cutaneous pharyngeal fistulae.

Authors:  A R Maw; R J Lavelle
Journal:  J Laryngol Otol       Date:  1972-08       Impact factor: 1.469

6.  Pharyngo-cutaneous fistulae in totally laryngectomized patients.

Authors:  K Bresson; H Rasmussen; P A Rasmussen
Journal:  J Laryngol Otol       Date:  1974-09       Impact factor: 1.469

7.  The pectoralis major musculocutaneous island flap in single-stage reconstruction of the pharyngoesophageal region.

Authors:  S D Theogaraj; W H Merritt; G Acharya; I K Cohen
Journal:  Plast Reconstr Surg       Date:  1980-03       Impact factor: 4.730

8.  Surgery after organ preservation therapy. Analysis of wound complications.

Authors:  A M Sassler; R M Esclamado; G T Wolf
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1995-02

9.  Complications after laryngectomy.

Authors:  D N Weingrad; R H Spiro
Journal:  Am J Surg       Date:  1983-10       Impact factor: 2.565

10.  Impact of pharyngeal closure technique on fistula after salvage laryngectomy.

Authors:  Urjeet A Patel; Brian A Moore; Mark Wax; Eben Rosenthal; Larissa Sweeny; Oleg N Militsakh; Joseph A Califano; Alice C Lin; Christian P Hasney; R Brent Butcher; Jamie Flohr; Demetri Arnaoutakis; Matthew Huddle; Jeremy D Richmon
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2013-11       Impact factor: 6.223

View more
  1 in total

Review 1.  Non-Surgical Strategies for Assisting Closure of Pharyngocutaneous Fistula after Total Laryngectomy: A Systematic Review of the Literature.

Authors:  Luca Giovanni Locatello; Giuseppe Licci; Giandomenico Maggiore; Oreste Gallo
Journal:  J Clin Med       Date:  2021-12-24       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.